Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction.Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A financing…
Reunion Neuroscience’s $103 Million Series A Financing Round
![](https://globallegalchronicle.com/wp-content/uploads/2024/05/reunion-neurosciences-103-million-series-a-financing-round_663b345aae1bf.jpeg)